Neurobehavioral Mechanisms of Emotion Regulation in Depression Across the Adult Lifespan
Lifespan
3 other identifiers
observational
296
1 country
2
Brief Summary
The aim of this study is to test a model of demographic (age, sex), clinical, cognitive, and neurocircuitry predictors of emotion regulation ability and long-term depressive symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2017
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2017
CompletedFirst Posted
Study publicly available on registry
July 2, 2017
CompletedStudy Start
First participant enrolled
October 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2023
CompletedDecember 20, 2023
December 1, 2023
6.1 years
June 30, 2017
December 14, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Success of emotion regulation strategy use.
Self-reported negative affect and arousal following the use of reappraisal and distraction strategies
baseline
Depression symptom severity
Severity of depressive symptoms as measured by self report
6 months
Depression symptom severity
Severity of depressive symptoms as measured by self report
12 months
Study Arms (2)
MDD patients
Participants ages 35-75 determined to be clinically depressed via structured clinical interview. No interventions will be administered as part of this study.
non-MDD patients
Participants ages 35-75 determined to be lifetime free of psychiatric conditions as assessed by structured clinical interview. No interventions will be administered as part of this study.
Interventions
Patients will undergo fMRI imaging to assess areas of the brain that are active during emotion regulation. No clinical benefit of MRI imaging is anticipated.
Eligibility Criteria
100 MDD and 100 non-depressed (ND) adult qualifying participants ranging in age from 35-75
You may qualify if:
- age 35-75
- No MRI contra-indications (e.g., metal in body)
- Not currently pregnant
- Ambulatory
- No known uncorrected sensory deficits
- Estimated verbal IQ of 85+ as indicated by the North American Adult Reading test MDD group: Current MDD assessed by history of MDD as assessed by standardized SCID interview
- Control Group: no lifetime of history of MDD as assessed by standardized SCID interview
You may not qualify if:
- History of moderate or severe substance dependence, as assessed by standardized SCID interview
- History of psychosis, mania, or eating disorders, as assessed by standardized SCID interview
- Disorders with impact on brain characteristics (e.g., epilepsy, Parkinson's Disease) or history of stroke
- Contraindications to MRI scanning, as indicated on the MRI safety screening questionnaire
- Use of antidepressants or other psychotropics other than sleep aids in the past 4 weeks (8 weeks for fluoxetine)
- Indication of mild cognitive impairment or dementia. To meet screening criteria, participants must meet all of the following:
- Scoring of 24 or higher on the Montreal Cognitive Assessment;
- perform above 1.5 standard deviations on the following measures: HVLT delayed recall, Trail Making B, and Animal Naming based normative values
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (2)
Civitan Building, Duke Psychiatry and Behavioral Sciences
Durham, North Carolina, 27705, United States
Psychiatry and Behavioral Services
Durham, North Carolina, 27705, United States
Related Publications (4)
Nienhuis FJ, van de Willige G, Rijnders CA, de Jonge P, Wiersma D. Validity of a short clinical interview for psychiatric diagnosis: the mini-SCAN. Br J Psychiatry. 2010 Jan;196(1):64-8. doi: 10.1192/bjp.bp.109.066563.
PMID: 20044664BACKGROUNDWinecoff A, Labar KS, Madden DJ, Cabeza R, Huettel SA. Cognitive and neural contributors to emotion regulation in aging. Soc Cogn Affect Neurosci. 2011 Apr;6(2):165-76. doi: 10.1093/scan/nsq030. Epub 2010 Apr 12.
PMID: 20385663BACKGROUNDLevenson RW, Carstensen LL, Friesen WV, Ekman P. Emotion, physiology, and expression in old age. Psychol Aging. 1991 Mar;6(1):28-35. doi: 10.1037//0882-7974.6.1.28.
PMID: 2029364BACKGROUNDKnight BG, Maines ML, Robinson GS. The effects of sad mood on memory in older adults: a test of the mood congruence effect. Psychol Aging. 2002 Dec;17(4):653-61. doi: 10.1037//0882-7974.17.4.653.
PMID: 12507361BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Moria Smoski, PhD
Duke Department of Psychiatry
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 30, 2017
First Posted
July 2, 2017
Study Start
October 10, 2017
Primary Completion
November 20, 2023
Study Completion
November 20, 2023
Last Updated
December 20, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share
This study qualifies as a NDA data sharing study under NIMH guidelines, therefore data will be shared to NDCT.